ReviewFrontiers in oncology2026

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review.

Anvitha Nagaraj Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.